Fymika 250mg Injection
Marketer
Sanify Healthcare Pvt Ltd
Salt Composition
Amikacin (250mg)
Overview Fymika 250mg Injection
Cefixime 250mg Injection is a broad-spectrum antibiotic combating numerous bacterial infections. These infections can affect various body systems, including the urinary tract, bones, joints, respiratory system (such as pneumonia), central nervous system, and bloodstream. Prophylactic use is also indicated in hospitalized patients. Cefixime's mechanism involves inhibiting bacterial growth. Administration, strictly by a healthcare professional, occurs intravenously or intramuscularly. Self-administration is prohibited. Adherence to the prescribed dosage schedule is crucial; omitting doses or prematurely halting treatment risks relapse or infection exacerbation. Typical side effects encompass injection site reactions and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy warrant medical consultation. High-dose therapy may induce vertigo, nephrotoxicity, and ototoxicity. Consequently, diligent adherence to medical guidance is vital, potentially including regular kidney function, hearing, and urine analysis. Pregnancy contraindicates its use; disclose pregnancy, pregnancy intentions, or breastfeeding to your physician.
Uses of Fymika 250mg Injection
Infections caused by bacteria
Major Benefits of Fymika 250mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Fymika 250mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Fymika 250mg Injection:
This medication will be administered by your physician or their designated nurse. Self-medication is strictly prohibited.
How Fymika 250mg Injection works:
Banflox 250mg Injection is a bactericidal medication. Its mechanism of action involves inhibiting the production of crucial bacterial proteins, thereby disrupting essential bacterial processes.
SAFETY ADVICE
AlcoholSAFE
Fymika 250mg Injection's concurrent use with alcohol presents no known adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Administering Fymika 250mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in critical circumstances where a physician deems the potential benefits outweigh the inherent dangers. Physician consultation is mandatory.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Fymika, 250mg dose, poses no known breastfeeding risk. Research in humans indicates minimal drug transfer to breast milk, suggesting negligible infant harm.
DrivingUNSAFE
Administering Fymika 250mg Injection may induce drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving if such effects are experienced.
KidneyCAUTION
Patients with impaired kidney function should use Fymika 250mg Injection cautiously. A modified dosage of Fymika 250mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Fymika 250mg Injection in individuals with liver impairment is likely safe. Available evidence indicates dose modification may be unnecessary; however, physician consultation is recommended.
What if you forget to take Fymika 250mg Injection :
Should you forget a scheduled dose of Fymika 250mg Injection, seek medical advice.
Facts to Know About Fymika 250mg Injection
| Label | Value |
|---|---|
| Chemical Category | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Actions | Aminoglycoside antibiotics |
3,018 People bought this recently